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Exposure to high glucose concentrations in vitro is often employed as a model for understanding ery-
throcyte modiﬁcations in diabetes. However, effects of such experiments may be affected by glucose
consumption during prolonged incubation and changes of cellular parameters conditioned by impaired
energy balance. The aim of this study was to compare alterations in various red cell parameters in this
type of experiment to differentiate between those affected by glycoxidation and those affected by energy
imbalance. Erythrocytes were incubated with 5, 45 or 100 mM glucose for up to 72 h. High glucose
concentrations intensiﬁed lipid peroxidation and loss of activities of erythrocyte enzymes (glutathione S-
transferase and glutathione reductase). On the other hand, hemolysis, eryptosis, calcium accumulation,
loss of glutathione and increase in the GSSG/GSH ratio were attenuated by high glucose apparently due
to maintenance of energy supply to the cells. Loss of plasma membrane Ca2þ-ATPase activity and de-
crease in superoxide productionwere not affected by glucose concentration, being seemingly determined
by processes independent of both glycoxidation and energy depletion. These results point to the ne-
cessity of careful interpretation of data obtained in experiments, in which erythrocytes are subject to
treatment with high glucose concentrations in vitro.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Hyperglycemia is the most important factor in the onset and
progress of diabetic complications. Diabetes mellitus is a metabolic
disorder resulting in decreased number of pump units on the er-
ythrocyte membrane, altered lipid–protein interactions, enzyme
glycation and peroxidation which account for many complications
[1]. Human erythrocytes are continuously exposed to glucose in
plasma during their circulatory life span of 120 days. Passive
transport through insulin-independent glucose transporter,
GLUT1, ensures that the glucose concentration in the erythrocyte
cytosol is close to that in the plasma, normally about 5 mM, and
increased under conditions of hyperglycemia [2]. The erythrocytes
and their membranes have always been objects of studies as theyB.V. This is an open access article u
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a-Bartosz).play an important role in various physiological and metabolic
events. Human erythrocyte properties such as deformability and
elasticity are affected by Ca2þ ions [3,4] whose level is regulated
by plasma membrane Ca2þ-ATPase (PMCA). A rise in internal Ca2þ
concentration leads to changes in cell shape and volume, increased
cellular rigidity, and hemolysis [5,6].
Ca2þ-ATPase activity of erythrocyte membranes is known to be
decreased in diabetic patients with elevated blood glucose [7,8]
and in red blood cells (RBCs) treated ex vivo with glucose [9], and
there is evidence to suggest that such effects are related to gly-
cation of plasma membrane Ca2þ-ATPase (PMCA) [10,11]. How-
ever, Raftos et al. found that Vmax of active Ca2þ extrusion from
intact RBCs is unaffected by their exposure in vivo or in vitro to
high concentration of glucose for up to 6 h [12].
The red blood cell membrane contains approximately equal
weight amounts of lipids and proteins [1]. Lipid peroxidation alters
the microenvironment of membrane bound enzymes by changing
phospholipids and fatty acid composition [13]. In addition, mem-
brane proteins are also glycated, which may lead to decrease in
their activities [14]. Hyperglycemia in diabetes mellitus causes
glycation of membrane enzymes along with oxidative stress
leading to decrease in activity of Naþ/Kþ-ATPase and other
changes in erythrocyte membranes [1].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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istic feature of biological membranes. Phospholipids containing
amino groups such as phosphatidylserine (PS) are localized mainly
or exclusively in the inner leaﬂet of the plasma membrane [15].
Loss of membrane lipid asymmetry is associated with a number of
physiological and pathological events [16]. Under hyperglycemic
conditions, the concentration of glucose metabolite methylglyoxal
is dramatically elevated in plasma as well as in erythrocytes. In-
creased concentration of methylglyoxal induces exposure of PS on
the outer surface of erythrocytes, disrupting the asymmetry of
membrane phospholipids [17]. As erythrocytes lack nucleus and
mitochondria, death of erythrocytes has been called eryptosis [18]
to distinguish it from apoptosis of nucleated cells. Increase of both,
eryptosis and advanced glycation products, was reported in high
glucose (40 and 100 mM) treated erythrocytes [19].
Incubation of erythrocytes under conditions of high glucose
concentrations is usually used as a model to mimic the in vivo
situation of hyperglycemia in diabetes. However, another aspect of
this type of experiments should be taken into account: if no glu-
cose is added during the incubation, cells incubated with initial
physiological concentration of glucose utilize it during the in-
cubation while those incubated with high glucose have longer
supply of energy source. As a result, some their parameters, not so
strongly affected by glycation, change less than in control ery-
throcytes incubated with initially physiological levels of glucose.
We noted such a phenomenon in preliminary experiments; this
study was aimed at comparison of behavior of several parameters
critical for the function of erythrocytes during incubation with
initially physiological glucose concentration (5 mM) and with high
glucose (45 and 100 mM). We expected to identify by this ap-
proach those parameters whose changes are mainly dependent on
glycation and those whose changes depend critically on main-
tenance of the energy balance of erythrocytes.Material and methods
Ethical approval
The study was approved by the Research Bioethics Committee
of the University of Łódź (Poland).
Chemicals and equipment
All basic reagents were from Sigma-Aldrich Company (Poznan,
Poland). All reagents used were of analytical reagent grade. All the
spectrophotometric analyses were done using a Varian Cary
50 UV–vis spectrophotometer (Varian Inc., Cary, NC, USA). Fluor-
escence was read using an Inﬁnite 200 PRO multimode reader
(Tecan Group Ltd., Männedorf, Switzerland).
Glucose incubation routine
Freshly drawn human whole blood was obtained from the
Blood Bank in Łódź. Blood was centrifuged (2000g, 10 min, 4 °C),
plasma and leukocyte buffy coat were aspirated and the ery-
throcyte pellet was washed three times with 4 volumes of phos-
phate buffered saline (PBS; 1 tablet of PBS/100 ml H2O) per 1 vo-
lume of a suspension. Residual leukocytes were removed by pas-
sing erythrocyte suspensions through a 1:1 (w/w) mixture of a
cellulose and microcrystalline cellulose [20].
Washed red blood cells (RBCs) were suspended to a ﬁnal he-
matocrit of 10% in PBS containing varying concentrations of glu-
cose (5, 45 or 100 mM) and 10 μM ampicillin, and incubated at
37 °C for 24, 48 and 72 h with continuous mixing. The moderately
high (45 mM) and very high (100 mM) glucose concentrationsemployed had been applied in earlier studies by other authors
[9,12,21–23]. Erythrocytes suspended in PBS-glucose (5 mM) were
used as a control, because of normal blood glucose level in non-
diabetic humans before meal is about 4–5.9 mM.
Preparation of erythrocyte ghosts
Erythrocyte ghosts were prepared from washed erythrocytes
according to the method of Dodge et al. with some modiﬁcations
[24]. Brieﬂy, after incubation, erythrocytes were hemolyzed on ice
with 20 volumes of 20 mM phosphate buffer, pH 7.4, containing
1 mM ethylenediaminetetraacetatic acid (EDTA) and 0.5 mM
phenylmethylsulfonyl ﬂuoride (PMSF) as proteolytic inhibitors,
and centrifuged at 4 °C at 20,000g for 20 min. The ghosts were
resuspended in ice-cold 10 mM and then 5 mM phosphate buffer,
pH 7.4 containing 0.1 mM EDTA, centrifuged and this process was
continued until the ghosts were free from residual hemoglobin.
Finally, the erythrocyte ghosts were resuspended in 20 mM
phosphate buffer, pH 7.4. The protein concentration was estimated
by the method of Lowry et al. [25].
Flow cytometry analysis
For evaluation of eryptosis, erythrocytes (6% hematocrit) were
washed in annexin-V-binding buffer containing: 125 mM NaCl,
10 mM HEPES (pH 7.4) and 5 mM CaCl2. Erythrocytes were then
stained with FITC-Annexin V at a 1:20 dilution and mixed gently
on a vortex mixer. After 20 min incubation in the dark at room
temperature, samples were diluted 1:5, thoroughly mixed to ob-
tain single cell suspensions, and analyzed by ﬂow cytometry in a
Becton Dickinson LSR II cytometer. Cell volume differences were
estimated by forward scatter (FSC), and FITC-annexin-ﬂuorescence
intensity was measured in the FL-1 channel with an excitation
wavelength of 488 nm and an emission wavelength of 530 nm as
previously described [17].
Measurement of intracellular Ca2þ in erythrocytes was per-
formed according to Nicolay et al. [17]. Brieﬂy, erythrocytes were
loaded with Fluo-3/AM (Calbiochem, Bad Soden, Germany) by
addition of 10 ml of a Fluo-3/AM stock solution (2.0 mM in di-
methylsulfoxide) to 10 ml erythrocyte suspension (0.16% hemato-
crit) in Ringer solution. The cells were incubated for 15 min under
vigorous shaking. An additional 10 ml of a Fluo-3/AM was added
and the cells were incubated 25 min. Fluo-3/AM-loaded ery-
throcytes were centrifuged at 1000g at 22 °C and washed twice
with Ringer solution containing 0.5% bovine serum albumin (BSA)
and once with albumin-free Ringer buffer. Fluo-3/AM-loaded er-
ythrocytes were analyzed by forward and side scatter and Ca2þ-
dependent ﬂuorescence intensity was measured in the FL-1
channel with an excitation wavelength of 488 nm and an emission
wavelength of 530 nm using Becton Dickinson LSR II cytometer
(BD Biosciences Franklin Lakes, New Jersey, USA).
Ca2þ-ATPase activity
After the treatment, ATPase activity was estimated as described
previously [26]. Brieﬂy, the membranes obtained by lysis and
washing with 20 mM borate buffer instead of phosphate to avoid
high phosphate background were diluted with the assay medium
(ﬁnal concentrations: 10 mMMgCl2, 1 mM ATP, 1 mM ethylene glycol
tetraacetic acid (EGTA), 0.1 mM ouabain in 100 mM Tris–HCl buffer)
and incubated at 37 °C in the presence or absence of 1 mM calcium
lactate, at a protein concentration of 1.5 mg/ml, for 30 min. Samples
incubated on ice served as blanks. Incubation was stopped by addi-
tion of an equal volume (70 ml) of 10% trichloroacetic acid, the sam-
ples were centrifuged and 100 ml aliquots of the supernatants were
added to eppendorf tubes containing 1 ml of deionized water. Then
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w/v (NH4)6Mo7O24 H2O in 3.15 M H2SO4), incubated for 10 min,
added with 200 ml of 0.035% Malachite Green in 0.35% w/v polyvinyl
alcohol and incubated at room temperature for another 30 min. Then
absorbance of the samples was measured at 620 nm. The Ca2þ-AT-
Pase activity was calculated as the difference between the activity
measured with calcium lactate and the basal activity measured
without calcium.
Measurement of glycated hemoglobin
Glycated hemoglobin content was measured spectro-
photometrically by the method of Standefer and Eaton [27] and
expressed as a percent of total hemoglobin. Glycosylation of he-
moglobin was expressed as mmoles of 5-(hydroxymethyl)-2-fur-
aldehyde (HMF)/g hemoglobin.
Measurement of intracellular superoxide
Intracellular superoxide was estimated by labeling cells with
dihydroethidine (Karlsruhe, Germany) in the dark at 37 °C for
20 min. The probe was added to a ﬁnal concentration of 5 mM. A
total of 105 cells were counted with an LSRII multicolor ﬂow
cytometer (Becton Dickinson).
Lipid peroxidation assay
This assay is dependent upon the sensitivity of the ﬂuorophore
BODIPY (581/591) C11 to oxidation by peroxyl/alkoxyl radicals [28].
This probe readily incorporates into biological membranes and
responds to free radical attack with a spectral emission shift from
red to green, which can be readily monitored and quantiﬁed by
ﬂow cytometry [29].
Enzymatic activities
Catalase
Catalase activity was determined according to Aebi [30]. To
1 ml of 54 mM H2O2 in 50 mM phosphate buffer, pH 7.0 and
1.95 ml of 50 mM phosphate buffer, pH 7.0, 50 μl of hemolysate
was added and the decrease in hydrogen peroxide concentration
was measured spectrophotometrically at 240 nm, at 25 °C during
1 min. The kinetic curves were analyzed using the Cary-WinUV-
software. One unit of enzyme activity was deﬁned as the activity
required to degrade 1 μmol of hydrogen peroxide in 60 s. Enzyme
activity was expressed as units per mg of Hb (U/mg Hb).
Glutathione S-transferase (GST)
GST activity was determined by the method described by Habig
et al. [31]. 250 μl of 0.02 M glutathione (GSH) in 0.1 M phosphate
buffer, pH 6.5, was added to 750 μl of 0.1 M phosphate buffer, pH
6.5. 10 μl of 0.1 M chloro-2,4-dinitrobenzene (CDNB) in ethanol
and 10 μl of hemolysate was added to the cuvette. The increase of
absorbance was measured at a wavelength of 340 nm for 3 min
against the reagent blank. Enzyme activity was expressed as units
per gram of Hb (U/g Hb).
Glutathione reductase (GR)
GR activity was determine using Glutathione Reductase Assay
(RANDOX, GR2368).
Hemolysis assay
Following incubation, the samples were centrifuged (5000g,
10 min, 23 °C) and hemoglobin content in the supernatant was
read at 540 nm (A). A value of 100% lysis was assigned to the su-
pernatant of the sample with control hemolysate, obtained byfreezing and thawing the cell suspensions (A1). The percentage of
hemolysis (H) in each assay tube was calculated by the equation:
H A A% / 1001[ ] = *
Estimation of GSH and GSSG content
Glutathione determination was performed according to Senft
et al. [32] as modiﬁed by Robaszkiewicz et al. [33]. Suspension of
RBCs in PBS (hematocrit of 16%) treated with different con-
centrations of glucose was centrifuged (5000g, 10 min, 23 °C). The
pellet was washed three times with PBS. Proteins of the ery-
throcyte pellet were precipitated with RQB-TCA buffer (20 mM
HCl, 5 mM diethylenetriaminepentaacetic acid, 10 mM ascorbic
acid, 5% trichloroacetic acid (TCA)), then centrifuged (5000g,
10 min, 23 °C) and the supernatant was taken for GSH and GSSG
assay.
For GSH determination, 2 μl of deproteinized supernatant di-
luted to 25 μl with RQB-TCA were put on two wells (denoted ‘ ’
and ‘þ ’) of a 96-well black plate. The sample ‘þ ’ was added with
4 μl of 7.5 mM N-ethylmaleimide in RQB-TCA, both samples added
with 40 μl of 1 M potassium phosphate buffer, pH 7.0, mixed for
1 min and incubated at room temperature for 5 min. Then 160 μl
of 0.1 M potassium phosphate buffer was added, followed by 25 μl
of 0.5% o-phtalaldehyde in methanol and the plate was shaken
(1 min). After 30-min incubation (room temperature) the ﬂuor-
escence was read at 355 nm/460 nm. The value obtained for the
‘ ’ sample was subtracted from that obtained for the ‘þ ’ value
and GSH concentration was read from a calibration curve obtained
with glutathione as a standard.
For determining GSSG concentration, two paired samples, ‘ ’
and ‘þ ’, each containing 25 μl of deproteinized supernatant, were
added with 4 μl of 7.5 mM N-ethylmaleimide in RQB-TCA and
40 μl of 1 M potassium phosphate buffer. Then, 5 μl of 100 mM
sodium dithionite in RQB-TCA was introduced into the sample ‘þ ’.
The mixture was incubated at room temperature for 60 min. The
remaining part of the procedure was the same as for GSH esti-
mation. The calibration curve was prepared with GSSG.
Hemoglobin assay
Hemoglobin (Hb) concentration was estimated according to the
Drabkin’s method [34]. 20 μL of the hemolysate was added to
5000 μL of the Drabkin reagent (0.03% K3[Fe(CN)6], 0.1% NaHCO3,
0.005% KCN) and incubated for 15 min; then the absorbance was
measured at a wavelength of 540 nm against a reagent blank. All
the spectrophotometric analyses were done using a Varian Cary 50
UV–vis spectrophotometer (Varian Inc., Cary, NC, USA). Fluores-
cence was read using an Inﬁnite 200 PRO multimode reader (Tecan
Group Ltd., Switzerland).
Statistical analysis
Data were expressed as means of the percentage of control7S.
D. Statistical comparison between groups was performed using the
one-way ANOVA followed by Bonferroni test for mutual comparison
of treated samples with control and by STATISTICS, version 10
(2010; StatSoft Inc., Tulsa, OK, USA). Differences among means were
considered signiﬁcant at *po0.05, **po0.01 and ***po0.001.Results
The level of glycated hemoglobin in control samples (5 mM
glucose) was practically not changed with increasing time of in-
cubation. High concentrations of glucose induced glycation of
hemoglobin in 48 h (100 mM glucose) and 72 h of incubation (45
and 100 mM glucose) (Fig. 1).
When erythrocytes were incubated with normal (5 mM), high
(45 mM) and extremely high (100 mM) concentrations of glucose
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Fig. 1. Hemoglobin glycation after incubation of erythrocytes with high glucose. 5-
Hydroxymetylfurfural (HMF) formation was used to estimate hemoglobin glyca-
tion. Incubation of RBCs with 5 mM glucose for 24, 48 and 72 h did not result to any
changes in the level of glycated hemoglobin. Signiﬁcant increase (po0.05) of
glycated hemoglobin by 100 mM glucose at 48 h of incubation and by 45 mM
glucose (po0.05) and 100 mM glucose (po0.01) at 72 h of incubation was
observed.
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Fig. 2. Effect of incubation in various glucose concentrations on erythrocyte
membrane PMCA activity. Signiﬁcant decrease of PMCA activities of all glucose
concentrations in comparison with starting (0 h) values were observed for all time
intervals. No signiﬁcant differences were observed by comparing high level glu-
cose-treated cells with control cells for the same time intervals.
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Fig. 3. Effect of incubation in various glucose concentrations on intracellular cal-
cium level of erythrocytes. Intracellular calcium was determined with Fluo-3/AM
using ﬂow cytometry. Signiﬁcant increase of intracellular calcium in comparison
with starting values were observed for all glucose concentrations after incubation
of erythrocytes for 48 and 72 h (po0.001). Signiﬁcant decrease (po0.01) of cal-
cium level by 100 mM glucose in comparison with low level of glucose at 48 h of
incubation was observed. Signiﬁcant decrease (po0.001) of calcium level by
100 mM glucose to compare with low level of glucose at 72 h of incubation was
found.
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Fig. 4. Effect of erythrocyte incubation in various glucose concentrations on er-
yptosis. Eryptosis was measured by exposure of phosphatidylserine by ﬂuorescence
of Annexin-V using ﬂow cytometry. All glucose concentrations induced signiﬁcant
increase of eryptosis in comparison with starting values (0 h) after incubation of
erythrocytes for 72 h (po0.001). Signiﬁcant decrease (po0.01) of eryptosis by 45
and 100 mM glucose in comparison with 5 mM glucose after 72 h was observed.
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cubation time in control sample (5 mM glucose) as well as in
samples incubated with 45 mM or 100 mM glucose. There was no
signiﬁcant effect of glucose concentration on the loss of PMCA
activity (Fig. 2).
Cytosolic calcium concentration increased in control sample
(5 mM glucose) incubated for up to 48 and 72 h. The presence of
high glucose concentrations (45 mM and 100 mM) decreased the
level of calcium after incubation for up to 48 h when compared to
samples with 5 mM glucose (Fig. 3). Eryptosis signiﬁcantly in-
creased only after incubation of the cells with 5 mM glucose for up
to 72 h. High glucose levels attenuated eryptosis in comparison
with control samples (5 mM glucose) after 72-h incubation (Fig. 4).
Increase of hemolysis was observed with 5 mM glucose and in-
cubation time of up to 48 and 72 h. Under conditions of high
concentrations of glucose hemolysis was attenuated and observed
only after the longest incubation time (72 h; Table 1).
Effect of high glucose on erythrocyte redox balance was de-
termined by evaluation of intracellular superoxide level, lipid
peroxidation, the level of reduced and oxidized glutathione. In
addition, activities of redox-related enzymes (catalase, GR and GST
were estimated as markers of possible redox imbalance (Table 1)).The intracellular content of superoxide declined with increasing
incubation time in control erythrocytes and in cells with both high
concentrations of glucose (Fig. 5). No signiﬁcant differences in the
superoxide level were found between samples with high glucose
(45 mM and 100 mM) in comparison with the control (5 mM
glucose). Lipid peroxidation had a tendency to a time-dependent
increase in all samples tested, which, however, did not reach sta-
tistical signiﬁcance except for samples containing 100 mM of
glucose where the increase after 72 h was statistically signiﬁcant
(Fig. 6). The activity of catalase decreased drastically in control
samples (containing 5 mM glucose) after 48 h and 72 h of in-
cubation (Table 1). 45 mM glucose prevented the decrease of
catalase activity observed in control cells; however, a decrease was
observed in samples incubated with 100 mM glucose. In control
samples (5 mM glucose) signiﬁcant decreases of both GSH and
GSSG were observed within the whole period of time tested (24–
72 h). Glucose (45 and 100 mM) attenuated both GSH and GSSG
decrease after 48 and 72 h. The activity of GST was decreased by
prolonged incubation at high glucose concentrations (48 h for
45 mM glucose, 48 h and 72 h for 100 mM glucose). GR activity
was decreased by incubation in high glucose (24–72 h for 45 mM
glucose, 48 and 72 h for 100 mM glucose) (Table 1).
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Fig. 5. Effect of incubation in various glucose concentrations on superoxide pro-
duction in erythrocytes.
Dihydroethidine (DHE) was used to measure superoxide level. All glucose con-
centrations induced signiﬁcant decrease of superoxide level in comparison with
starting values (0 h) after incubation of erythrocytes for 48 and 72 h (po0.05).
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Fig. 6. Lipid peroxidation in erythrocytes after incubation in various glucose con-
centrations. All glucose concentrations induced signiﬁcant increase of lipid per-
oxidation in comparison with starting values (0 h) after incubation of erythrocytes
for 24, 48 and 72 h (po0.001). Signiﬁcant increase (po0.01) of lipid peroxidation
induced by 100 mM glucose in comparison with 5 mM glucose after 72 h of in-
cubation was observed.
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Glycated hemoglobin is a minor fraction of hemoglobin in hu-
man erythrocytes, generated in vivo by nonenzymatic binding of
glucose to N-terminal amino acids of beta chains of hemoglobin A
[35,36]. The extent of hemoglobin glycation depends on the age of
erythrocytes and glucose concentration in blood. Amount of gly-
cated hemoglobin is higher in older as well as in diabetic ery-
throcytes. Both intracellular and membrane proteins of ery-
throcytes are glycated under hyperglycemic conditions [36]. We
observed time-dependent increase in hemoglobin glycation under
high glucose conditions.
Energy production in the form of ATP is necessary for main-
taining erythrocyte function: keeping ion gradients across the
membrane via ATP-dependent membrane pumps, maintenance of
asymmetry of the membrane phospholipids, synthesis of glu-
tathione and other metabolites, and protection of hemoglobin,
enzymes and membrane proteins against oxidative impairment
[37].
In the course of incubation within 0, 24, 48 and 72 h of control
human erythrocytes with 5 mM glucose in PBS, degradative pro-
cesses were observed in this study: decrease of Ca2þ-ATPase ac-
tivity, increase of cytosolic calcium level, increase of eryptosis,
hemolysis, lipid peroxidation and decrease of antioxidant potential
as indicated by increasing GSSG/GSH ratio. This may be caused
mainly by consumption of glucose as a main substrate for en-
ergetic metabolism of erythrocytes [38], associated with decrease
of ATP concentration. Energy in erythrocytes is generated only by
glycolysis and the pentose phosphate shuttle as these cells lack
J. Viskupicova et al. / Redox Biology 5 (2015) 381–387386mitochondria. The presence of high levels of glucose (45 and
100 mM) did not affect the decrease in PMCA activity.
Intracellular calcium content in control samples, as well as in
erythrocytes treated with high concentrations of glucose increased
after 48 and 72 h, correlating with reduction of PMCA activity.
Calcium content in erythrocytes treated with 45 mM glucose for
up to 24, 48 and 72 h and with 100 mM glucose for up to 24 h was
practically equal to that of control erythrocytes. Raftos et al. [12]
reported normal (not changed) calcium extrusion in erythrocytes
after incubation of intact RBCs in the presence of 30–100 mM
glucose for up to 6 h. However, after incubation of erythrocytes
with 100 mM glucose for up to 48 and 72 h, decrease in calcium
content was observed in comparison with samples incubated with
5 mM glucose. The decrease of calcium under conditions of high
glucose may be due to an adaptive mechanisms operating by al-
ternative calcium transport out of cell via NCX transporter. In-
creased calcium concentration induces eryptosis in erythrocytes
[18]. To assess the extent of eryptosis, we tested level the phos-
phatidylserine (PS) exposure, which is a marker of eryptosis. Er-
yptosis increased in control samples (5 mM glucose) incubated for
up to 72 h and was lower in RBCs incubated with 45 and 100 mM
glucose for up to 72 h than in the control. Energy depletion is well
known to induce and mediate apoptosis [39]. Apparently, cells
incubated with high glucose, having available source of metabolic
energy, were able to counteract apoptosis to some extent.
High glucose concentration has been shown to generate su-
peroxide and other free radicals from the autooxidation of glucose
and glycated proteins with concomitant increase in cellular lipid
peroxidation, membrane damage in different cell systems and in
diabetic blood [40–42]. We observed decrease of superoxide level
independent of glucose concentration up to 72 h. This ﬁnding is
somewhat puzzling since hemoglobin autoxidation is believed to
be the main source of superoxide in erythrocytes [43] and this
reaction is expected to be accelerated by glutathione loss [44].
Moreover, dramatic differences in the behavior of GSH con-
centration between control and high glucose-treated erythrocytes
were not reﬂected by the rate of superoxide production. Another
source of superoxide in erythrocytes may be NADPH oxidase [45].
The loss of activity of this enzyme may be the main reason for the
observed loss of superoxide production in erythrocytes.
In control erythrocytes a progressive loss of GSH concentration
and increase in the GSSG/GSH ratio was observed. Glutathione is
an important intracellular antioxidant maintained in the reduced
state by the pentose phosphate cycle (which utilizes 3–11% of
glucose in erythrocytes), which is a single pathway generating
NADPH, necessary for reduction of GSSG [46]. The loss of GSH and
the increase in the GSSG/GSH was prevented by high glucose.
Oxidative stress in erythrocytes induced by glucose was re-
ported to increase membrane lipid peroxidation in diabetic tissue
pathology [1,39,46]. Also high glucose treated human erythrocytes
enhanced lipid peroxidation [47]. In our study, high glucose con-
centrations enhanced lipid peroxidation.
Hemolysis was attenuated by high glucose concentrations. This
result contradicts the data of Marar [48] who found hemolysis to
increase with increasing glucose concentrations after 24-h in-
cubation at 37 °C. The reason for this discrepancy is unclear.
A factor not addresses in the present study is the osmotic effect
induced by high glucose concentrations. The effect is changeable
with time since as glucose is consumed during the incubation.
However, it may contribute to the decrease in hemolysis by high
glucose concentrations.
In summary, we observed three types of behavior of erythrocyte
parameters studied on glucose concentration. Lipid peroxidation, loss
of activities of GST and GR were intensiﬁed by high glucose con-
centrations. Apparently, these parameters are signiﬁcantly affected
by glycoxidation. Loss of PMCA activity and superoxide productionwere independent of glucose concentration and most probably
conditioned by processes independent of glycation and also not
signiﬁcantly dependent on the energy balance of erythrocytes. He-
molysis, eryptosis, calcium accumulation, loss of glutathione and
increase in the GSSG/GSH ratio were attenuated by high glucose
apparently due to maintenance of energy supply to the cells. Catalase
activity decreased in control erythrocytes, most probably due to
depletion of NADPH necessary for maintaining the enzyme activity
[49] and in erythrocytes incubated with 100 mM but not 45 mM
glucose, apparently due to glycation. These results point to the ne-
cessity of careful interpretation of data obtained in experiments in
which erythrocytes are subject to treatment with high glucose con-
centrations in vitro.Conﬂict of interest
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